» Articles » PMID: 33438846

Blood MRNA Expression Profiles of Autophagy, Apoptosis, and Hypoxia Markers on Blood Cardioplegia and Custodiol Cardioplegia Groups

Overview
Date 2021 Jan 13
PMID 33438846
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Blood cardioplegia (BC) and Custodiol cardioplegia (CC) have been used for a long time in open heart surgery and are highly effective solutions. The most controversial issue among these two is whether there is any difference between them regarding myocardial damage after ischemia surgery. In this study, autophagy, apoptosis, and hypoxia markers were investigated and that way we evaluated the differences between BC and CC patients.

Methods: A total of 30 patients were included in this study, using two different cardioplegic solutions. Three different whole blood samples of the patients were taken from a central vein (preoperatively, immediately postoperatively, and one day after surgery). Total ribonucleic acid was extracted from these samples. Quantitative real-time polymerase chain reaction was performed, and changes in gene expression were determined by the 2-∆∆Ct method of relative quantification.

Results: In the CC group, Beclin gene expression level was found to be higher and this difference was statistically significant (P=0.0024). Similarly, cysteine-aspartic acid protease (caspase) 9 and hypoxia-inducible factor 1α messenger ribonucleic acid (mRNA) gene expression level increased and were significantly different in the CC group. In the BC group, Beclin and microtubule-associated protein light chain 3 expressions were higher in the samples taken one day after surgery. Caspases 3 and 8 gene expressions were significantly different in the BC group.

Conclusion: As a result of the analysis performed between the two cardioplegia groups, it has been shown that CC harms the myocardium more than BC at the level of mRNA expression of related markers.

Citing Articles

Construction of a strain overexpressing the gene for increased HDMF production.

Wang Y, Wang X, Jiang P, Dai L, Hu Y, Pan B Food Sci Nutr. 2024; 12(6):4435-4442.

PMID: 38873477 PMC: 11167138. DOI: 10.1002/fsn3.4109.


Comparison of Single-Dose Cardioplegia in Valvular Heart Surgery: Lactated Ringer's-Based del Nido vs. Histidine-Tryptophan-Ketoglutarate Cardioplegia Solution.

Kantathut N, Luangpatom-Aram K, Khajarern S, Leelayana P, Cherntanomwong P Braz J Cardiovasc Surg. 2023; 38(6):e20220447.

PMID: 37801520 PMC: 10550254. DOI: 10.21470/1678-9741-2022-0447.


Comparison of Cardioplegic Solutions in Coronary Bypass Surgery Over Autophagy and Apoptosis Mechanisms.

Sener E, Hamurcu Z, Taheri S, Tahtasakal R, Delibasi N, Elcik D Arq Bras Cardiol. 2023; 120(7):e20220479.

PMID: 37466618 PMC: 10364987. DOI: 10.36660/abc.20220479.


Caspase-9: A Multimodal Therapeutic Target With Diverse Cellular Expression in Human Disease.

Avrutsky M, Troy C Front Pharmacol. 2021; 12:701301.

PMID: 34305609 PMC: 8299054. DOI: 10.3389/fphar.2021.701301.

References
1.
Chen S, Li Y, Wang D, Zhang G, Tan C . Expression of heme oxygenase-1, hypoxia inducible factor-1alpha, and ubiquitin in peripheral inflammatory cells from patients with coronary heart disease. Clin Chem Lab Med. 2009; 47(3):327-33. DOI: 10.1515/CCLM.2009.073. View

2.
BARNER H . Blood cardioplegia: a review and comparison with crystalloid cardioplegia. Ann Thorac Surg. 1991; 52(6):1354-67. DOI: 10.1016/0003-4975(91)90034-n. View

3.
Singh K, Yanagawa B, Quan A, Wang R, Garg A, Khan R . Autophagy gene fingerprint in human ischemia and reperfusion. J Thorac Cardiovasc Surg. 2013; 147(3):1065-1072.e1. DOI: 10.1016/j.jtcvs.2013.04.042. View

4.
Viana F, Shi W, Hayward P, Larobina M, Liskaser F, Matalanis G . Custodiol versus blood cardioplegia in complex cardiac operations: an Australian experience. Eur J Cardiothorac Surg. 2012; 43(3):526-31. DOI: 10.1093/ejcts/ezs319. View

5.
Rupinder S, Gurpreet A, Manjeet S . Cell suicide and caspases. Vascul Pharmacol. 2007; 46(6):383-93. DOI: 10.1016/j.vph.2007.01.006. View